Rallybio Corp
For the period ended Jun 30, 2024. Filed Aug 8, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 8, 2024
RLYB$15.76+0.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity
Condensed Consolidated Statements of Changes in Stockholders' Equity
| FOR THE THREE MONTHS ENDED JUNE 30, 2024 AND 2023 · COMMON · ADDITIONAL PAID-INCAPITAL · ACCUMULATED DEFICIT · ACCUMULATED OTHER COMPREHENSIVE LOSS · STOCKHOLDERS' EQUITY | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (in thousands, except share amounts) · SHARES · AMOUNT | ||||||||||||||
| March 31, 2023 | 37,746,214 | $4 | $333,253 | $(177,999) | $(61) | $155,197 | ||||||||
| Share-based compensation expense | — | — | 2,692 | — | — | 2,692 | ||||||||
| Issuance of common stock from the stock purchase plan | 43,423 | — | 209 | — | — | 209 | ||||||||
| Issuance of common stock from the stock award plan | 1,219 | — | — | — | — | — | ||||||||
| Net loss | — | — | — | (18,630) | — | (18,630) | ||||||||
| Other comprehensive loss | — | — | — | — | (211) | (211) | ||||||||
| Balance, June 30, 2023 | 37,790,856 | $4 | $336,154 | $(196,629) | $(272) | $139,257 | ||||||||
| March 31, 2024 | 37,811,970 | $4 | $343,498 | $(254,274) | $(71) | $89,157 | ||||||||
| Share-based compensation expense | — | — | 1,915 | — | — | 1,915 | ||||||||
| Issuance of common stock upon completion of a securities purchase agreement, net of offering costs of $268 | 3,636,363 | — | 5,137 | — | — | 5,137 | ||||||||
| Issuance of common stock under the stock purchase plan | 38,289 | — | 44 | — | — | 44 | ||||||||
| Issuance of common stock under the stock award plan | 1,925 | — | — | — | — | — | ||||||||
| Forfeiture of restricted common stock | (961) | — | — | — | — | — | ||||||||
| Net loss | — | — | — | (16,236) | — | (16,236) | ||||||||
| Other comprehensive loss | — | — | — | — | — | — | ||||||||
| Balance, June 30, 2024 | 41,487,586 | $4 | $350,594 | $(270,510) | $(71) | $80,017 | ||||||||
| FOR THE SIX MONTHS ENDED JUNE 30, 2024 AND 2023 · COMMON · ADDITIONAL PAID-INCAPITAL · ACCUMULATED DEFICIT · ACCUMULATED OTHER COMPREHENSIVE GAIN (LOSS) · STOCKHOLDERS' EQUITY | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (in thousands, except share amounts) · SHARES · AMOUNT | |||||||||||||||
| December 31, 2022 | 37,837,369 | $4 | $330,208 | $(160,681) | $(214) | $169,317 | |||||||||
| Share-based compensation expense | — | — | 5,737 | — | — | 5,737 | |||||||||
| Issuance of common stock under the stock award plan | 1,219 | — | — | — | — | — | |||||||||
| Issuance of common stock from the stock purchase plan | 43,423 | — | 209 | — | — | 209 | |||||||||
| Forfeiture of restricted common stock | (91,155) | — | — | — | — | — | |||||||||
| Net loss | — | — | — | (35,948) | — | (35,948) | |||||||||
| Other comprehensive loss | — | — | — | — | (58) | (58) | |||||||||
| Balance, June 30, 2023 | 37,790,856 | $4 | $336,154 | $(196,629) | $(272) | $139,257 | |||||||||
| December 31, 2023 | 37,829,565 | $4 | $341,410 | $(235,245) | $15 | $106,184 | |||||||||
| Share-based compensation expense | — | — | 4,003 | — | — | 4,003 | |||||||||
| Issuance of common stock upon completion of a securities purchase agreement, net of offering costs of $268 | 3,636,363 | — | 5,137 | — | — | 5,137 | |||||||||
| Issuance of common stock under the stock purchase plan | 38,289 | — | 44 | — | — | 44 | |||||||||
| Issuance of common stock under the stock award plan | 1,925 | — | — | — | — | — | |||||||||
| Forfeiture of restricted common stock | (18,556) | — | — | — | — | — | |||||||||
| Net loss | — | — | — | (35,265) | — | (35,265) | |||||||||
| Other comprehensive loss | — | — | — | — | (86) | (86) | |||||||||
| Balance, June 30, 2024 | 41,487,586 | $4 | $350,594 | $(270,510) | $(71) | $80,017 | |||||||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.